Top View
- A Correlation Between the in Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans
- Discriminative Stimulus Properties of 3-Substituent Rimonabant Analogs
- “Psychoactive Substances Present in Salvia Divinorum Acquired in Smartshops Or in the Internet”
- Tea Polyphenols Attenuate Liver Inflammation by Modulating Obesity
- Rimonabant: a New Class of Drug to Fight Obesityobesity
- A Review on Obesity Management Through Natural Compounds and a Green Nanomedicine-Based Approach
- Rimonabant: a Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors Eli V
- Rimonabant Adds Appetizing Choice to Slim Obesity Market
- List Item Acomplia : EPAR
- Combating Obesity: Utilizing Natural and Chemical Compounds for Lipid Modifica- Tion- a Mini-Review
- Anti‑Obesity Effects of a Mixed Extract Containing Platycodon Grandiflorum, Apium Graveolens and Green Tea in High‑Fat‑Diet‑Induced Obese Mice
- (12) Patent Application Publication (10) Pub. No.: US 2017/0106.178 A1 ALTSCHUL Et Al
- Day 1 Scientific Tracks & Abstracts
- Salvia Divinorum: from Recreational Hallucinogenic Use to Analgesic and Anti-Inflammatory Action
- WHO Expert Committee on Drug Dependence Pre-Review ……………
- (12) Patent Application Publication (10) Pub. No.: US 2017/0135984 A1 Solomon (43) Pub
- The CB1 Inverse Agonist AM251, but Not the CB1 Antagonist AM4113, Enhances Retention of Contextual Fear Conditioning in Rats
- Potency Price List
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Endocannabinoid System: Role in Depression, Reward and Pain Control (Review)
- List of Drugs Prohibited for Manufacture and Sale
- What to Remember About Cannabis History Why Know
- A Guide to Targeting the Endocannabinoid System in Drug Design
- Pooled Analysis of Three Randomized, Double-Blind, Placebo Controlled Trials with Rimonabant for Smoking Cessation
- (12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Cannabidiol Displays Unexpectedly High Potency As an Antagonist of CB1 and CB2 Receptor Agonists in Vitro
- Pharmaceuticals: Restrictions in Use and Availability
- Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
- Acomplia, INN-Rimonabant
- Quantitativemetabolicchangesa
- Mecamylamine, Dihydro-Β-Erythroidine, and Dextromethorphan Block Conditioned Responding Evoked by the Conditional Stimulus Effects of Nicotine
- Cannabinoid Receptors in Myocardial Injury: a Brother Born to Rival
- The Molecular Logic of Endocannabinoid Signalling
- Cannabis: from a Plant That Modulates Feeding
- Targeting the Endocannabinoid CB1 Receptor to Treat Body
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- The Endocannabinoid 2-AG Controls Skeletal Muscle Cell Differentiation Via CB1 Receptor-Dependent Inhibition of Kv7 Channels
- Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists
- Free PDF Download
- The Two Tonttitulumluluttu Muhimu
- Investigations of Salvinorin A: Synthetic Isolation, Quantification, and in Vivo Characteristics
- Pharmacological Activity of Salvinorin A, the Major Component of Salvia Divinorum
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Adieu, Rimonabant Assocation, Touting “A Newly Discovered Failure of Weight-Loss Drug Physiological System
- Pharmacokinetics and Pharmacodynamics of Salvinorin a and Salvia Divinorum: Clinical and Forensic Aspects
- Download Product Insert (PDF)
- Levo-Tetrahydropalmatine Inhibits the Acquisition of Ketamine-Induced
- 022529Orig1s000
- A Radiotracer for PET Imaging of CB1 Cannabinoid Receptors
- Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia
- Exploring Opioid and Cannabis Pharmacology: Biased Signaling of Endogenous Opioid Peptides and Cannabimimetic Properties of Cannabis Sativa Terpenes
- Recent Advances in Understanding Nicotinic Receptor Signaling Mechanisms That Regulate Drug Self-Administration Behavior
- Thesis Effect of Short-Term Epigallocatechin-3-Gallate
- Therapeutic Potential of Cannabinoids in Schizophrenia
- National Drugs and Poisons Schedule Committee
- Toxicology Reference Material
- Effects of Rimonabant, a Cannabinoid CB1 Receptor Ligand, on Energy Expenditure in Lean Rats
- The Synthesis and Characterization of 2-Arachidonoyl Glycerol
- Cannabinoid CB1 Receptor Antagonist Rimonabant Attenuates Reinstatement of Ketamine Conditioned Place Preference in Rats